Log In
BCIQ
Print this Print this
 

Kytril, granisetron

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSerotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsTreat nausea and vomiting associated with anti-neoplastic agents and radiotherapy
Regulatory Designation
PartnerChugai Pharmaceutical Co. Ltd.;
Genentech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today